| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | EGF_1 | 1.59e-05 | 255 | 40 | 6 | PS00022 | |
| Domain | EGF_2 | 1.97e-05 | 265 | 40 | 6 | PS01186 | |
| Domain | LamGL | 2.68e-05 | 4 | 40 | 2 | SM00560 | |
| Domain | LamG-like | 2.68e-05 | 4 | 40 | 2 | IPR006558 | |
| Domain | EGF-like_CS | 2.26e-04 | 261 | 40 | 5 | IPR013032 | |
| Domain | EGF_extracell | 2.86e-04 | 60 | 40 | 3 | IPR013111 | |
| Domain | EGF_2 | 2.86e-04 | 60 | 40 | 3 | PF07974 | |
| Domain | Laminin_N | 5.27e-04 | 16 | 40 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 5.27e-04 | 16 | 40 | 2 | PS51117 | |
| Domain | Laminin_N | 5.27e-04 | 16 | 40 | 2 | PF00055 | |
| Domain | LamNT | 5.27e-04 | 16 | 40 | 2 | SM00136 | |
| Domain | ADAM_CR | 6.70e-04 | 18 | 40 | 2 | PF08516 | |
| Domain | KAZAL_1 | 6.70e-04 | 18 | 40 | 2 | PS00282 | |
| Domain | MetalloPept_cat_dom | 6.92e-04 | 81 | 40 | 3 | IPR024079 | |
| Domain | - | 6.92e-04 | 81 | 40 | 3 | 3.40.390.10 | |
| Domain | NTR | 7.47e-04 | 19 | 40 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 7.47e-04 | 19 | 40 | 2 | IPR018933 | |
| Domain | - | 8.29e-04 | 20 | 40 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 9.15e-04 | 21 | 40 | 2 | PF00200 | |
| Domain | DISIN | 9.15e-04 | 21 | 40 | 2 | SM00050 | |
| Domain | - | 1.10e-03 | 95 | 40 | 3 | 2.60.120.200 | |
| Domain | NTR | 1.10e-03 | 23 | 40 | 2 | PS50189 | |
| Domain | Netrin_domain | 1.10e-03 | 23 | 40 | 2 | IPR001134 | |
| Domain | ZINC_PROTEASE | 1.20e-03 | 98 | 40 | 3 | PS00142 | |
| Domain | TIMP-like_OB-fold | 1.41e-03 | 26 | 40 | 2 | IPR008993 | |
| Domain | ACR | 1.52e-03 | 27 | 40 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 1.52e-03 | 27 | 40 | 2 | IPR006586 | |
| Domain | EGF_LAM_2 | 1.87e-03 | 30 | 40 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 1.87e-03 | 30 | 40 | 2 | PS01248 | |
| Domain | Laminin_EGF | 2.54e-03 | 35 | 40 | 2 | PF00053 | |
| Domain | EGF_Lam | 2.54e-03 | 35 | 40 | 2 | SM00180 | |
| Domain | Kazal_2 | 2.69e-03 | 36 | 40 | 2 | PF07648 | |
| Domain | Laminin_EGF | 2.99e-03 | 38 | 40 | 2 | IPR002049 | |
| Domain | Peptidase_M12B_N | 3.15e-03 | 39 | 40 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 3.15e-03 | 39 | 40 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 3.31e-03 | 40 | 40 | 2 | PS00427 | |
| Domain | Reprolysin | 3.31e-03 | 40 | 40 | 2 | PF01421 | |
| Domain | Laminin_G_2 | 3.31e-03 | 40 | 40 | 2 | PF02210 | |
| Domain | ADAM_MEPRO | 3.31e-03 | 40 | 40 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.31e-03 | 40 | 40 | 2 | PS50214 | |
| Domain | Peptidase_M12B | 3.31e-03 | 40 | 40 | 2 | IPR001590 | |
| Domain | CYSTEINE_SWITCH | 3.48e-03 | 41 | 40 | 2 | PS00546 | |
| Domain | Disintegrin_dom | 3.48e-03 | 41 | 40 | 2 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 3.82e-03 | 43 | 40 | 2 | IPR001818 | |
| Domain | PSI | 4.00e-03 | 44 | 40 | 2 | IPR016201 | |
| Domain | LamG | 4.00e-03 | 44 | 40 | 2 | SM00282 | |
| Domain | PSI | 4.36e-03 | 46 | 40 | 2 | SM00423 | |
| Domain | KAZAL | 4.36e-03 | 46 | 40 | 2 | SM00280 | |
| Domain | Growth_fac_rcpt_ | 4.50e-03 | 156 | 40 | 3 | IPR009030 | |
| Domain | KAZAL_2 | 5.13e-03 | 50 | 40 | 2 | PS51465 | |
| Domain | Kazal_dom | 5.34e-03 | 51 | 40 | 2 | IPR002350 | |
| Domain | Laminin_G | 6.85e-03 | 58 | 40 | 2 | IPR001791 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 3.66e-07 | 394 | 41 | 7 | 27248496 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 9.23e-07 | 150 | 41 | 5 | 28242625 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 26784546 | ||
| Pubmed | 1.50e-05 | 1285 | 41 | 9 | 35914814 | ||
| Pubmed | Transcriptional analysis of Gli3 mutants identifies Wnt target genes in the developing hippocampus. | 2.38e-05 | 47 | 41 | 3 | 22235033 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.67e-05 | 146 | 41 | 4 | 23892456 | |
| Pubmed | 3.44e-05 | 529 | 41 | 6 | 14621295 | ||
| Pubmed | VEGF mediates commissural axon chemoattraction through its receptor Flk1. | 3.78e-05 | 8 | 41 | 2 | 21658588 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 4.52e-05 | 167 | 41 | 4 | 20362541 | |
| Pubmed | 4.80e-05 | 339 | 41 | 5 | 30415952 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 34732824 | ||
| Pubmed | 8.88e-05 | 12 | 41 | 2 | 21660050 | ||
| Pubmed | 1.10e-04 | 653 | 41 | 6 | 22586326 | ||
| Pubmed | A midline switch of receptor processing regulates commissural axon guidance in vertebrates. | 1.22e-04 | 14 | 41 | 2 | 20159958 | |
| Pubmed | 1.41e-04 | 15 | 41 | 2 | 36028553 | ||
| Pubmed | Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. | 1.61e-04 | 16 | 41 | 2 | 22780989 | |
| Pubmed | ZFYVE19 deficiency: a ciliopathy involving failure of cell division, with cell death. | 1.82e-04 | 17 | 41 | 2 | 38816193 | |
| Pubmed | Morphogenetic competence of HNF4 alpha-deficient mouse hepatic cells. | 2.05e-04 | 18 | 41 | 2 | 18617288 | |
| Pubmed | 2.27e-04 | 1429 | 41 | 8 | 35140242 | ||
| Pubmed | 2.34e-04 | 101 | 41 | 3 | 10997877 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.47e-04 | 1082 | 41 | 7 | 38697112 | |
| Pubmed | 2.48e-04 | 103 | 41 | 3 | 32744500 | ||
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 22863734 | ||
| Pubmed | 2.58e-04 | 486 | 41 | 5 | 20936779 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.76e-04 | 774 | 41 | 6 | 15302935 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.91e-04 | 271 | 41 | 4 | 32433965 | |
| Pubmed | 3.47e-04 | 808 | 41 | 6 | 20412781 | ||
| Pubmed | 4.00e-04 | 25 | 41 | 2 | 15229182 | ||
| Pubmed | 5.13e-04 | 132 | 41 | 3 | 34321664 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 5.36e-04 | 134 | 41 | 3 | 25452129 | |
| Pubmed | 5.78e-04 | 30 | 41 | 2 | 32562661 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 5.92e-04 | 583 | 41 | 5 | 29844126 | |
| Pubmed | 6.17e-04 | 31 | 41 | 2 | 30872278 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.91e-04 | 341 | 41 | 4 | 32971831 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 7.69e-04 | 351 | 41 | 4 | 38297188 | |
| Pubmed | A protein interaction network for pluripotency of embryonic stem cells. | 1.08e-03 | 41 | 41 | 2 | 17093407 | |
| Pubmed | WNT/RYK signaling restricts goblet cell differentiation during lung development and repair. | 1.13e-03 | 42 | 41 | 2 | 31776260 | |
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 1.13e-03 | 42 | 41 | 2 | 11439183 | |
| Cytoband | 1p34 | 3.79e-04 | 32 | 41 | 2 | 1p34 | |
| Cytoband | 1q21.3 | 4.95e-03 | 117 | 41 | 2 | 1q21.3 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 9.72e-04 | 27 | 31 | 2 | 47 | |
| GeneFamily | PHD finger proteins | 1.04e-02 | 90 | 31 | 2 | 88 | |
| Coexpression | NABA_MATRISOME | VEGFC RSPO2 LOXL4 ADAM30 PAPPA NTN1 NELL2 USH2A ADAM15 PLXNA2 WFIKKN2 | 2.55e-07 | 1026 | 40 | 11 | M5889 |
| Coexpression | NABA_MATRISOME | VEGFC RSPO2 LOXL4 ADAM30 PAPPA NTN1 NELL2 ADAM15 PLXNA2 WFIKKN2 | 2.00e-06 | 1008 | 40 | 10 | MM17056 |
| Coexpression | GSE3982_DC_VS_BCELL_DN | 1.21e-05 | 197 | 40 | 5 | M5470 | |
| Coexpression | BMI1_DN.V1_UP | 7.42e-05 | 147 | 40 | 4 | M2782 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.13e-04 | 738 | 40 | 7 | MM17058 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.26e-04 | 751 | 40 | 7 | M5885 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_CLUB_CELL | 1.68e-04 | 70 | 40 | 3 | M45690 | |
| Coexpression | GAO_STOMACH_24W_C6_PIT_CELL | 1.75e-04 | 13 | 40 | 2 | M39144 | |
| Coexpression | GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP | 1.95e-04 | 189 | 40 | 4 | M4921 | |
| Coexpression | GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN | 1.99e-04 | 190 | 40 | 4 | M6496 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.24e-04 | 196 | 40 | 4 | M3008 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP | 2.24e-04 | 196 | 40 | 4 | M8858 | |
| Coexpression | GSE3982_DC_VS_NKCELL_DN | 2.29e-04 | 197 | 40 | 4 | M5480 | |
| Coexpression | GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN | 2.29e-04 | 197 | 40 | 4 | M5475 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN | 2.29e-04 | 197 | 40 | 4 | M3472 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN | 2.33e-04 | 198 | 40 | 4 | M9346 | |
| Coexpression | GSE3982_DC_VS_BASOPHIL_DN | 2.38e-04 | 199 | 40 | 4 | M5473 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.26e-06 | 595 | 40 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#2 | 3.72e-05 | 100 | 40 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K2 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.80e-07 | 187 | 41 | 5 | d3563bb087e476baea5b59389e4d34d0ff98cac5 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 7.80e-07 | 187 | 41 | 5 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Club_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-05 | 153 | 41 | 4 | 77030b0e033f3635b1bbe7552a28c074ea7bb106 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-05 | 157 | 41 | 4 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 1.44e-05 | 161 | 41 | 4 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.59e-05 | 165 | 41 | 4 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.59e-05 | 165 | 41 | 4 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-05 | 166 | 41 | 4 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-05 | 166 | 41 | 4 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-05 | 166 | 41 | 4 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 174 | 41 | 4 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.38e-05 | 183 | 41 | 4 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.49e-05 | 185 | 41 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.54e-05 | 186 | 41 | 4 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.54e-05 | 186 | 41 | 4 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| ToppCell | 15-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 2.65e-05 | 188 | 41 | 4 | 9a64fb07de611de38d6f24673feb3b81a5e85384 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-05 | 188 | 41 | 4 | a37edd8f9e4a4e336b5acbb0407d3d275975cee8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-05 | 189 | 41 | 4 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.71e-05 | 189 | 41 | 4 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 2.76e-05 | 190 | 41 | 4 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.76e-05 | 190 | 41 | 4 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-05 | 191 | 41 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 192 | 41 | 4 | bacbaef1f230051335f4433e55db07a161b96b4c | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.88e-05 | 192 | 41 | 4 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 192 | 41 | 4 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-05 | 194 | 41 | 4 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 195 | 41 | 4 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.06e-05 | 195 | 41 | 4 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-05 | 195 | 41 | 4 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | 11.5-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 3.06e-05 | 195 | 41 | 4 | 8cbc78a6cb812f907c69b00f85263976216840ac | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 196 | 41 | 4 | a20a56d8997d6db2a10046c8801c619a379de83c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 196 | 41 | 4 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 197 | 41 | 4 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-05 | 197 | 41 | 4 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | distal-3-Epithelial-Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.18e-05 | 197 | 41 | 4 | 72ac9068cfd8f04c521a858d55eb8b5764de0282 | |
| ToppCell | AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-05 | 197 | 41 | 4 | fd7bdfa6bf5966ebc11fdd13915769429540ddbf | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-05 | 197 | 41 | 4 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 197 | 41 | 4 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.24e-05 | 198 | 41 | 4 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | distal-Epithelial-Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.24e-05 | 198 | 41 | 4 | dda0bf3a48f738df590ce23b891d82be19e10d66 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-05 | 199 | 41 | 4 | a3ec743b978ba8fdf1677b4971b5731f50ddd30f | |
| ToppCell | Substantia_nigra|World / BrainAtlas - Mouse McCarroll V32 | 1.62e-04 | 115 | 41 | 3 | 18174b8d57d444fab1e9d2b13d22939c83c958e0 | |
| ToppCell | ASK454-Epithelial-Type_2|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.65e-04 | 136 | 41 | 3 | ff9a5e111993fdb3ac64c5ef269e3460ff994517 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-04 | 138 | 41 | 3 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-04 | 139 | 41 | 3 | b07929348ec9ad95d7bce33a7deac0938227b19f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-04 | 141 | 41 | 3 | 9a0f4bee2893da1b13ab89494e6159821d53538b | |
| ToppCell | COVID-19_Severe-dn_T|COVID-19_Severe / Disease condition and Cell class | 3.01e-04 | 142 | 41 | 3 | 2008033881b9e1b20926c3508d6ebdb6f1a1528f | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 143 | 41 | 3 | 6df16bf0324661cd9707df69cb39f4b5498d6d49 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-04 | 144 | 41 | 3 | 5665dd2839b6c8ddbf5ddb2d22e1ee6073f74c3b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.39e-04 | 148 | 41 | 3 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.39e-04 | 148 | 41 | 3 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.53e-04 | 150 | 41 | 3 | 57f21ad380fd1350a2c25d75ad8c3b763ded53ec | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-pDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-04 | 152 | 41 | 3 | 0c6dd41142e4ca1e54ca41e05e42ed29fbf0e570 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.67e-04 | 152 | 41 | 3 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-04 | 153 | 41 | 3 | c81a88d3f707487c511020d3960a1c41e706c6a0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-04 | 156 | 41 | 3 | a4b0e89255ea5d60198cb2b3e739981f9c9cf5c5 | |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-04 | 156 | 41 | 3 | 5d9e1df70f2e9219f6b029be2e39297605d36726 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | a9e077f686382303f0437ebfa4f11d273ba9fe40 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | fc127e7720649e746f3d3f5c2e9e63784767106a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-04 | 157 | 41 | 3 | d12f343454202da86a06d0369f8ffe5662cd091b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | 66a191cef4aa00811bb04462310d012610006f85 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-04 | 158 | 41 | 3 | 0c9bb7f8d080a052ca71701544a076c6c2ea67cd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-04 | 158 | 41 | 3 | cebb58878b6945074bc1c7d5848d842da5dcbae1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-04 | 158 | 41 | 3 | 2cfa6dd36c8ae534cf1dd49366d4b4433388c1e0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-04 | 158 | 41 | 3 | 6b51e5ee08e23924f5edbaf0a845a9232fb7ff7a | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-pDCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.11e-04 | 158 | 41 | 3 | 2af7beb48272e5368d9ba6b80f08d47ab8556c08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-04 | 158 | 41 | 3 | 8dd83a2a4c2ec9cdc3a03df8b51ee22bee1c2888 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.26e-04 | 160 | 41 | 3 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | CV-Mild-4|CV / Virus stimulation, Condition and Cluster | 4.26e-04 | 160 | 41 | 3 | be89efeeecb0de96ce136a7a62738f15dc0badb2 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.26e-04 | 160 | 41 | 3 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-04 | 160 | 41 | 3 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.34e-04 | 161 | 41 | 3 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 161 | 41 | 3 | 7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab | |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-04 | 162 | 41 | 3 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.42e-04 | 162 | 41 | 3 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-04 | 162 | 41 | 3 | f945688815229c8386cbcbf46deee7df316fa8d3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.42e-04 | 162 | 41 | 3 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 163 | 41 | 3 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.50e-04 | 163 | 41 | 3 | 453e0bb292baca2938d24582fedfd6a8bb1e78e9 | |
| ToppCell | Influenza_Severe-NK_CD56bright|Influenza_Severe / Disease group and Cell class | 4.50e-04 | 163 | 41 | 3 | 7748d5709e8cf6673f5a8370108309f76cd830f4 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 163 | 41 | 3 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells-Airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-04 | 164 | 41 | 3 | b1243b10591e1e15a94952e39ffbf382eae6aae8 | |
| ToppCell | LPS_only-Epithelial_airway-Club_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-04 | 164 | 41 | 3 | c5b2001280a43da855017361a3f6071a0e492848 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-04 | 164 | 41 | 3 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-04 | 165 | 41 | 3 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-04 | 165 | 41 | 3 | 23955e3373660f827518e723ac62fba99753f375 | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.66e-04 | 165 | 41 | 3 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-04 | 165 | 41 | 3 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | 390C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-04 | 166 | 41 | 3 | 4ba3711a02d3695b27f7cefd7c60e3be009f5bef | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-04 | 166 | 41 | 3 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-04 | 166 | 41 | 3 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | 390C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-04 | 166 | 41 | 3 | 35f6ae2664935dda0d883b32a050ced843204f2d | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.83e-04 | 167 | 41 | 3 | 78d264af390bd89942ffbb2991dc94f50756d4c9 | |
| ToppCell | facs-Aorta-Heart-24m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 167 | 41 | 3 | b85fd7ab21c80470bca804c788ce49a2bce763f8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.83e-04 | 167 | 41 | 3 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.91e-04 | 168 | 41 | 3 | 5ce3129a023a48a3d7e6b9306c1fc5addfef9675 | |
| Disease | cortical surface area measurement | RSPO2 PAPPA NTN1 CACHD1 RAPSN ADAM15 ITGB8 PLXNA2 SPTBN1 EPHA3 | 9.07e-06 | 1345 | 40 | 10 | EFO_0010736 |
| Disease | Intellectual Disability | 2.90e-05 | 447 | 40 | 6 | C3714756 | |
| Disease | neuroimaging measurement | 7.92e-05 | 1069 | 40 | 8 | EFO_0004346 | |
| Disease | level of Sterol ester (27:1/18:3) in blood serum | 8.01e-05 | 10 | 40 | 2 | OBA_2045193 | |
| Disease | brain measurement, neuroimaging measurement | 9.14e-05 | 550 | 40 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | basal cell carcinoma (is_implicated_in) | 1.17e-04 | 12 | 40 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 3.02e-04 | 19 | 40 | 2 | OBA_2045199 | |
| Disease | type 1 diabetes mellitus | 3.20e-04 | 242 | 40 | 4 | MONDO_0005147 | |
| Disease | seasonal gut microbiome measurement | 4.75e-04 | 112 | 40 | 3 | EFO_0007753 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 5.70e-04 | 26 | 40 | 2 | OBA_2045194 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 5.70e-04 | 26 | 40 | 2 | OBA_2045191 | |
| Disease | neuroimaging measurement, brain volume measurement | 6.00e-04 | 286 | 40 | 4 | EFO_0004346, EFO_0006930 | |
| Disease | sexual dimorphism measurement | 6.44e-04 | 1106 | 40 | 7 | EFO_0021796 | |
| Disease | hippocampal volume | 6.91e-04 | 297 | 40 | 4 | EFO_0005035 | |
| Disease | C-reactive protein measurement, high density lipoprotein cholesterol measurement | 9.78e-04 | 34 | 40 | 2 | EFO_0004458, EFO_0004612 | |
| Disease | triacylglycerol 58:10 measurement | 9.78e-04 | 34 | 40 | 2 | EFO_0010437 | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 1.04e-03 | 35 | 40 | 2 | EFO_0004458, EFO_0004611 | |
| Disease | orofacial cleft | 1.16e-03 | 37 | 40 | 2 | MONDO_0000358 | |
| Disease | urate measurement | 1.22e-03 | 895 | 40 | 6 | EFO_0004531 | |
| Disease | alcohol consumption measurement | 1.27e-03 | 1242 | 40 | 7 | EFO_0007878 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KCDQCDYACRQERHM | 496 | P49711 | |
| QAVCMHGRCASYAQQ | 516 | Q13444 | |
| RLCLNCHRMEQNECE | 956 | Q5VU97 | |
| MQSYHCRLNAARCDH | 1601 | A6QL64 | |
| CNCNLHARRCRFNME | 341 | O95631 | |
| LNVHYQMCRRHCCDI | 611 | Q6ZP01 | |
| RYAHNNDDAMLECRV | 151 | Q13702 | |
| SNNMLQCRCKYDGHR | 711 | Q96JB6 | |
| SRAEQRMNRLDQCYC | 256 | Q99435 | |
| CSERHNCMENSICRN | 401 | Q99435 | |
| NCMENSICRNLNDRA | 406 | Q99435 | |
| YNNPCMLCHENLIRQ | 1021 | Q9NQ38 | |
| NHMYSCRFSRQCVVD | 91 | P41235 | |
| CALHNMCSRRDKCQQ | 531 | O75051 | |
| KQHNGVCDMDCNYER | 451 | Q13219 | |
| HRLCNDLMNCVQERA | 36 | Q9BY11 | |
| HRACYRAMTNRCLLQ | 231 | Q99575 | |
| RIHNQCSDYNLDCMP | 206 | P26012 | |
| MSHDEQYCQCRGRLN | 346 | Q9UKF2 | |
| CRQIYEEANKTMRNC | 731 | Q9BZJ0 | |
| AGQEMCYVCLQRAQR | 321 | Q6ZN84 | |
| CANCEYELQMLRHRH | 381 | Q9NPF5 | |
| LCNNYIQMHLDLENC | 1911 | Q5TH69 | |
| PHNNRFMICCDRCEE | 276 | Q9BTC0 | |
| SMNCRCENNYFRADK | 301 | P29320 | |
| RNQDYKDICSRMQFC | 491 | P32019 | |
| NCALYSRAVEQQMDC | 401 | P51530 | |
| CLRSCFQDHMIRNCN | 386 | P51168 | |
| FQDHMIRNCNCGHYL | 391 | P51168 | |
| AMQLLRNCLYQNEEC | 1926 | Q86VV8 | |
| RYNLTIDNFQHCQMC | 886 | O75445 | |
| CCSRAYANHMINNHV | 781 | Q7Z3K3 | |
| IILNCMDYSHCQGNR | 11 | Q6UXX9 | |
| DRVAHMEFCYQELCQ | 611 | Q01082 | |
| NYMWNNHICRCLAQE | 246 | P49767 | |
| QCHSYADMRELRQAR | 2461 | Q6ZS81 | |
| MEQCHNYNARLCAER | 21 | Q92785 | |
| QCLDCAQRNLYRDVM | 31 | Q96JC4 | |
| KLCSDHCFNRYRMAN | 446 | Q9UBW7 | |
| MRKHAGDLRYQCNQC | 476 | P52746 | |
| NIHEHCQSYVEMQRC | 126 | Q96MF2 | |
| QCLDCAQQNLYRDVM | 31 | A0A1W2PQL4 | |
| CHRNLNHFETYEACM | 361 | Q8TEU8 | |
| AHLRCDACRAVAYQM | 46 | Q8WU39 |